Abstract |
Affibody molecules (6-7 kDa) are a new class of small robust three-helical scaffold proteins. Radiolabeled subnanomolar anti-HER2 affibody ZHER2:342 was developed for imaging of HER2 expression in tumors, and a clinical study has demonstrated that the (111)In- and (68)Ga-labeled affibody molecules can efficiently detect HER2 expressing metastases in breast cancer patients. However, a significant renal accumulation of radioactivity after systemic injection of a radiolabeled anti-HER2 affibody conjugate is observed. The aim of this study was to investigate the mechanism of renal reabsorption of anti-HER2 affibody at the molecular level. Renal accumulation of radiolabeled anti-HER2 affibody molecules was studied in a murine model and in vitro using opossum-derived proximal tubule (OK) cells. It was found that kidney reabsorption of affibody molecule was not driven by megalin/ cubilin. Amino acids in the target-binding side of affibody molecule were involved in binding to OK cells. On OK cells, two types of receptors for anti-HER2 affibody molecule were found: KD1=0.8 nM, Bmax1=71,500 and KD2=9.2 nM, Bmax2=367,000. The results of the present study indicate that affibody molecule and other scaffold-based targeting proteins with a relatively low kidney uptake can be selected using in vitro studies with tubular kidney cells.
|
Authors | Mohamed Altai, Zohreh Varasteh, Karl Andersson, Annemarie Eek, Otto Boerman, Anna Orlova |
Journal | Cancer biotherapy & radiopharmaceuticals
(Cancer Biother Radiopharm)
Vol. 28
Issue 3
Pg. 187-95
(Apr 2013)
ISSN: 1557-8852 [Electronic] United States |
PMID | 23461385
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Heterocyclic Compounds, 1-Ring
- Immunoconjugates
- Indium Radioisotopes
- Radiopharmaceuticals
- Recombinant Fusion Proteins
- affibody (ZHER2-342)2
- 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
- Technetium
- Receptor, ErbB-2
|
Topics |
- Animals
- Cell Line, Tumor
- Female
- Heterocyclic Compounds, 1-Ring
(chemistry, pharmacokinetics)
- Humans
- Immunoconjugates
(pharmacokinetics)
- Indium Radioisotopes
(chemistry)
- Kidney
(metabolism)
- Male
- Mice
- Molecular Imaging
(methods)
- Opossums
- Ovarian Neoplasms
(diagnostic imaging, metabolism)
- Radiopharmaceuticals
(pharmacokinetics)
- Receptor, ErbB-2
(analysis, biosynthesis)
- Recombinant Fusion Proteins
(pharmacokinetics)
- Technetium
(chemistry)
- Tissue Distribution
- Tomography, Emission-Computed, Single-Photon
|